<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04112290</url>
  </required_header>
  <id_info>
    <org_study_id>17-011376</org_study_id>
    <nct_id>NCT04112290</nct_id>
  </id_info>
  <brief_title>A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy</brief_title>
  <official_title>A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to understand more about various heart rhythms
      (electrical problems) in persons with hypertrophic cardiomyopathy with and without sleep
      apnea.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adult patients with hypertrophic cardiomyopathy and without known atrial fibrillation or
      pacemaker/implantable cardiac defibrillation will undergo implantable loop recorder
      implantation. No direct interventions will be performed. Prospective observation of atrial
      and ventricular arrhythmia incidence and burden will be assessed, with additional analyses
      performed based on the presence or absence of obstructive sleep apnea.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 5, 2019</start_date>
  <completion_date type="Anticipated">November 5, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 5, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Atrial fibrillation incidence in hypertrophic cardiomyopathy</measure>
    <time_frame>Final incidence to be calculated at study conclusion, after 3 years of rhythm monitoring.</time_frame>
    <description>Define the incidence ratio of newly diagnosed atrial fibrillation in hypertrophic cardiomyopathy, with and without sleep apnea</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Atrial fibrillation recurrence in hypertrophic cardiomyopathy</measure>
    <time_frame>Final recurrence rate to be calculated at study conclusion, after 3 years of rhythm monitoring.</time_frame>
    <description>Determine the frequency of recurrent atrial fibrillation in hypertrophic cardiomyopathy, with and without sleep apnea</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventricular arrhythmia incidence in hypertrophic cardiomyopathy</measure>
    <time_frame>Final incidence to be calculated at study conclusion, after 3 years of rhythm monitoring.</time_frame>
    <description>Define the incidence ratio of newly diagnosed ventricular arrhythmias in hypertrophic cardiomyopathy, with and without sleep apnea</description>
  </primary_outcome>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Hypertrophic Cardiomyopathy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with hypertrophic cardiomyopathy who are participating in (or previously
        participated in) Mayo Clinic study 17-003514 and/or 16-009474
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Currently or previously enrolled in 17-003514 and 16-009474

          -  Adults age &gt;18 years-old with a diagnosis of hypertrophic cardiomyopathy

          -  Both sexes

          -  Able to consent

        Exclusion Criteria:

          -  Vulnerable study population

          -  Known atrial fibrillation

          -  Pacemaker/ICD implantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Geske, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jasmine Sexton, CCRP</last_name>
    <phone>507-538-7178</phone>
    <email>Sexton.Jasmine@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeremy B Smith</last_name>
    <phone>507-255-2831</phone>
    <email>Smith.Jeremy@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jasmine Sexton, CCRP</last_name>
      <phone>507-538-7178</phone>
      <email>Sexton.Jasmine@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jeremy B Smith</last_name>
      <email>Smith.Jeremy@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jeffrey Geske, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virend Somers, M.D., Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Choudhary Anwar Chahal, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Konstantinos Siontis, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shahid Karim, M.B., Ch.B.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shreyas Venkataraman, M.B.B.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Meghna Mansukhani, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Noseworthy, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan Bukartyk, M.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sean Caples, D.O., M.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yong-Mei Cha, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Foley, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul Friedman, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard Gersh, M.B., Ch.B.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amar Killu, M.B.B.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grace Lin, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rick Nishimura, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Olson, Ph.D., M.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steve Ommen, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aiswarya Rajendran, M.B.B.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Rea, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Phillip Schulte, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erik St Louis, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>September 28, 2019</study_first_submitted>
  <study_first_submitted_qc>September 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 2, 2019</study_first_posted>
  <last_update_submitted>December 14, 2019</last_update_submitted>
  <last_update_submitted_qc>December 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Jeffrey B. Geske</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Ventricular tachycardia</keyword>
  <keyword>Arrhythmia</keyword>
  <keyword>Hypertrophic cardiomyopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Cardiomyopathy, Hypertrophic</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

